CD19/CD20 CAR/TRuC-T

· Shenzhen University General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/CD20 CAR/TRuC-T, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma [Phase 1, Phase 2]